Toxic hepatitis associated with amoxicillin-clavulanic acid in a chronic viral hepatitis B patient: A case report;Kronik viral hepatit b tanisi olan hastada amoksisilin-klavulonik asit kullanimina bağli gelişen toksik hepatit: Olgu sunumu

Medical Journal of Bakirkoy

Volumn 12, Issue 2, 2016, Pages 92-95

  Kurtgöz, Pervin Özkan ^a   Tünay, Havva ^a   Kurban, Fatma ^a   Kurtgöz, Serkan ^b   Demir, Kasim ^a   Acartürk, Gürsel ^a  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

^b ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

Amoxicillin clavulanic acid; Toxic hepatitis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID;

ADULT; ARTICLE; CASE REPORT; CHRONIC HEPATITIS B; DRUG SAFETY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MIDDLE AGED; TOXIC HEPATITIS; TREATMENT RESPONSE; TREATMENT WITHDRAWAL;

EID: 84976477270     PISSN: 13059319     EISSN: 13059327     Source Type: Journal    
DOI: 10.5350/BTDMJB201612208     Document Type: Article

References (25)

1. Bissell DM, Gores GJ, Laskin DL, et al. Drug-induced liver injury:mechanisms and test systems. Hepatology 2001; 33: 1009-1013.
2. Danan G, Benichou C. Causality assessment of adverse reactions to drugs: I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993; 46: 1323-1330.
3. Benichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol 1990; 11: 272-276.
4. Polson JE. Hepatotoxicity due to antibiotics. Clin Liver Dis 2007; 11:549-561.
5. Thiim M, Friedman LS. Hepatotoxicity of antibiotics and antifungals. Clin Liver Dis 2003; 7: 381-399.
6. Simmons C. Beware: antibiotic-induced hepatotoxicity is rare but deadly. Hosp Pharm 2002; 37: 326-330.
7. Chalasani N, Fontana RJ, Bonkovsky HL, et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008; 135: 1924-1934.
8. Andrade RJ, López-Ortega S, López-Vega MC, et al. Idiosyncratic drug hepatotoxicity: a 2008 update. Expert Rev Clin Pharmacol 2008; 1: 261-276.
9. Robles M, Andrade RJ. Hepatotoxicidad por antibioticos:actualizacion en 2008 [in Spanish (Hepatotoxicity by antibiotics:update in 2008); abstract in English]. Rev Esp Quimioter 2008; 21:224-233.
10. Andrade RJ, Lucena MI, Fernandez MC, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 2005; 129: 512-521.
11. Björnsson E, Jerlstad P, Bergqvist A, et al. Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden. Scand J Gastroenterol 2005; 40: 1095-1101.
12. Björnsson E, Olsson R. Suspected drug-induced liver fatalities reported to the WHO database. Dig Liver Dis 2006; 38: 33-38.
13. Lucena MI, Andrade RJ, Fernandez MC, et al. Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity:aprospective series from Spain. Hepatology 2006; 44: 850-866.
14. Larrey D, Vial T, Micaleff A, et al. Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases. Gut 1992; 33: 368-371.
15. Salvo F, Polimeni G, Moretti U, et al. Adverse drug reactions related to amoxicillin alone and in association with clavulanic acid: data from spontaneous reporting in Italy. J Antimicrob Chemother 2007; 60: 121-126.
16. Brown SJ, Desmond PV. Hepatotoxicity of antimicrobial agents. Semin Liver Dis 2002; 22: 157-167.
17. Fontana RJ, Shakil AO, Greenson JK, et al. Acute liver failure due to amoxicillin and amoxicillin/clavulanate. Dig Dis Sci 2005; 50: 1785-1790.
18. Andrade RJ, Lucena MI, Fernandez MC, et al. Hepatotoxicity in patients with cirrhosis an often unrecognized problem lessons from a fatal case related to Amoxicillin/Clavulanic acid: Case report. Dig Dis and Sci 2001; 46: 1416-1419.
19. Colmenero JD, Reguera JM, Martos F, et al. Complications associated with brucella melitensis infection: a study of 530 cases. Medicine 1996; 75: 195-211.
20. Namiduru M, Gungor K, Dikensoy O, Baydar I, Ekinci E, Karaoglan I. Epidemiological, clinical and laboratory features of brucellosis: a prospective evaluation of 120 adult patients. Int J Clin Pract 2003; 57: 20-24.
21. Thomson JA, Fairley CK, Ugoni AM, et al. Risk factors for the development of amoxycillin-clavulanic acid associated jaundice. Med J Aust 1995; 162: 638-640.
22. de Abajo FJ, Montero D, Madurga M, Garcia Rodriguez LA. Acute and clinically relevant drug-induced liver injury: A population based case-control study. Br J Clin Pharmacol 2004; 58: 71-80.
23. Rochon J, Protiva P, Seeff LB, et al. Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in druginduced liver. Hepatol 2008; 48: 1175-1183.
24. Kaplowitz N. Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov 2005; 4: 489-499.
25. Andrade RJ, Lucena MI, Alonso A, et al. HLA class II genotype influences the type of liver injury in druginduced idiosyncratic liver disease. Hepatology 2004; 39: 1603-1612.